Population-based Incidence of Myopericarditis after COVID-19 Vaccination in Danish Adolescents

Ulrikka Nygaard*, Mette Holm, Cathrine Bohnstedt, Qing Chai, Lisbeth Samsø Schmidt, Ulla Birgitte Hartling, Jens Jakob Herrche Petersen, Jesper Thaarup, Jesper Bjerre, Niels Grove Vejlstrup, Klaus Juul, Lone Graff Stensballe

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.

OriginalsprogEngelsk
TidsskriftPediatric Infectious Disease Journal
Vol/bind41
Udgave nummer1
Sider (fra-til)E25-E28
ISSN0891-3668
DOI
StatusUdgivet - jan. 2022

Bibliografisk note

Funding Information:
The study was funded by a COVID-19 grant from the National Ministry of Higher Education and Science (grant no. 0237-00004B).

Publisher Copyright:
© 2021 Wolters Kluwer Health, Inc. All rights reserved.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Population-based Incidence of Myopericarditis after COVID-19 Vaccination in Danish Adolescents'. Sammen danner de et unikt fingeraftryk.

Citationsformater